0001709401-18-000001.txt : 20180301 0001709401-18-000001.hdr.sgml : 20180301 20180301141418 ACCESSION NUMBER: 0001709401-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180301 DATE AS OF CHANGE: 20180301 EFFECTIVENESS DATE: 20180301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-306744 FILM NUMBER: 18656169 BUSINESS ADDRESS: STREET 1: 325 VASSAR STREET, SUITE 1A CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: 325 VASSAR STREET, SUITE 1A CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001709401 Rubius Therapeutics, Inc. 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA MASSACHUSETTS 02139 617-679-9600 DELAWARE VL26, Inc. None Corporation true 2013 Joanne Protano 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Executive Officer Torben Straight Nissen 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Executive Officer Director David Epstein 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Director Robert S. Langer 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Director Roger Pomerantz 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Director Michael Rosenblatt 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Director Noubar B. Afeyan 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Director Francis Cuss 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Director Catherine Sohn 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Director Andrew Oh 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Executive Officer Christopher L. Carpenter 325 VASSAR STREET, SUITE 1A Cambridge MA MASSACHUSETTS 02139 Executive Officer Biotechnology Decline to Disclose 06b false 2018-02-23 false true false 0 101200005 101200005 0 Amount sold shown in item 13 and number of investors shown in item 14 includes $20,199,963 from 6 non-US investors. false 27 0 0 0 false Rubius Therapeutics, Inc. /s/Joanne Protano Joanne Protano Secretary 2018-03-01